Point72 Hong Kong LTD Amphastar Pharmaceuticals, Inc. Transaction History

Point72 Hong Kong LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$38.65 - $43.48 $77,261 - $86,916	-1,999 Reduced 83.29%	401 $16,000
Q1 2024 May 15, 2024	BUY	$42.85 - $63.45 $102,840 - $152,280	2,400 New	2,400 $105,000
Q3 2022 Nov 14, 2022	SELL	$27.56 - $37.75 $58,206 - $79,728	-2,112 Reduced 44.05%	2,683 $75,000
Q2 2022 Aug 15, 2022	BUY	$29.79 - $42.29 $81,177 - $115,240	2,725 Added 131.64%	4,795 $167,000
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $47,527 - $75,451	2,070 New	2,070 $74,000
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $2,521 - $3,237	-139 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $2,478 - $2,987	139 New	139 $3,000
Q4 2019 Feb 14, 2020	SELL	$17.07 - $20.64 $307 - $371	-18 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.12 - $22.62 $344 - $407	18 New	18 $0
Q3 2018 Nov 14, 2018	SELL	$15.39 - $19.38 $1,231 - $1,550	-80 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.6 $833 - $1,117	-57 Reduced 41.61%	80 $1,000
Q1 2018 May 15, 2018	BUY	$17.23 - $20.35 $2,360 - $2,787	137 New	137 $3,000

279

36.8M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.58B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.